Researchers from Memorial Sloan Kettering Cancer Center and Columbia University Irving Medical Center, both based in New York City, followed 1,024 patients at an urban academic medical center who received oral anticancer drug prescriptions from Jan. 1, 2018, to Dec. 31, 2019. Their study was published in JAMA Network Open.
The study found the top reasons for not receiving a prescription were:
- Clinician-directed change in decision-making — 30 percent
- Clinical deterioration — 18 percent
- Patient-directed change — 16 percent
- Financial access — 13 percent
- Transfer of care — 12 percent
- Loss to follow-up — 6 percent
